Cargando…

Antituberculosis drug-induced hepatotoxicity in children

Recent increases in the dosages of the essential antituberculosis agents isoniazid (INH), rifampicin (RMP), pyrazinamide (PZA) for use in children recommended by World Health Organization have raised concerns regarding the risk of hepatotoxicity. Published data relating to the incidence and pathogen...

Descripción completa

Detalles Bibliográficos
Autor principal:	Donald, Peter R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3133498/ https://www.ncbi.nlm.nih.gov/pubmed/21772953 http://dx.doi.org/10.4081/pr.2011.e16

Ejemplares similares

Unusual Recurrence of Antituberculosis Drug-Induced Hepatotoxicity in Children: A Case Series
por: Nataprawira, Heda Melinda, et al.
Publicado: (2021)

Association of PXR and CAR Polymorphisms and Antituberculosis Drug-Induced Hepatotoxicity
por: Wang, Yu, et al.
Publicado: (2019)

Genetic polymorphisms of N-acetyltransferase 2 & susceptibility to antituberculosis drug-induced hepatotoxicity
por: Sharma, Surendra K., et al.
Publicado: (2016)

Genetic and Functional Evaluation of the Role of FOXO1 in Antituberculosis Drug-Induced Hepatotoxicity
por: Zhang, Jingwei, et al.
Publicado: (2021)

Antituberculosis Drug-Induced Hepatotoxicity in IranianTuberculosis Patients: Role of Isoniazid Metabolic Polymorphism
por: Sistanizad, Mohammad, et al.
Publicado: (2011)

NAT2 and CYP2E1 polymorphisms and antituberculosis drug‐induced hepatotoxicity in Peruvian patients
por: Jaramillo‐Valverde, Luis, et al.
Publicado: (2022)

Gender-Dimorphic Impact of PXR Genotype and Haplotype on Hepatotoxicity During Antituberculosis Treatment
por: Wang, Jann Yuan, et al.
Publicado: (2015)

Diagnosis of Hypersensitivity Induced by Antituberculosis Drugs
por: Wu, Yuqing, et al.
Publicado: (2021)

HLA-DQ B1*0201 and A1*0102 Alleles Are Not Responsible for Antituberculosis Drug-Induced Hepatotoxicity Risk in Spanish Population
por: Leiro-Fernández, Virginia, et al.
Publicado: (2016)

Acquired Resistance to Antituberculosis Drugs
por: Aung, Htin Lin, et al.
Publicado: (2018)

Risk factors associated with adverse reactions to antituberculosis drugs
por: Resende, Laíse Soares Oliveira, et al.
Publicado: (2015)

New Antituberculosis Drugs: From Clinical Trial to Programmatic Use
por: Gualano, Gina, et al.
Publicado: (2016)

Antituberculosis Drug-Induced Fixed Drug Eruption: A Case Report
por: Vaghela, Jitendra H., et al.
Publicado: (2018)

Population Pharmacokinetic Properties of Antituberculosis Drugs in Vietnamese Children with Tuberculous Meningitis
por: Panjasawatwong, Navarat, et al.
Publicado: (2020)

Antituberculosis Targeted Drug Delivery as a Potential Future Treatment Approach
por: Mazlan, Mohd Khairul Nizam, et al.
Publicado: (2021)

Mycobacterium tuberculosis resistance to antituberculosis drugs in Mozambique,
por: Pires, Germano Manuel, et al.
Publicado: (2014)

Connexin-based signaling and drug-induced hepatotoxicity
por: Maes, Michaël, et al.
Publicado: (2017)

Hepatotoxicity Due to Antituberculosis Therapy among Paediatric Patients Seen at the University of Ilorin Teaching Hospital, North Central Nigeria
por: Aishatu, Gobir, et al.
Publicado: (2017)

ABCC2 Haplotype is Associated With Antituberculosis Drug-Induced Maculopapular Eruption
por: Kim, Sang-Heon, et al.
Publicado: (2012)

Naringenin mitigates antituberculosis drugs induced hepatic and renal injury in rats
por: Sahu, Nisha, et al.
Publicado: (2019)

Mycobacterium tuberculosisβ-Carbonic Anhydrases: Novel Targets for Developing Antituberculosis Drugs
por: Aspatwar, Ashok, et al.
Publicado: (2019)

Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis
por: Gafar, Fajri, et al.
Publicado: (2023)

Adverse Reactions to Antituberculosis Drugs in Iranian Tuberculosis Patients
por: Farazi, Aliasghar, et al.
Publicado: (2014)

Seizures following Intoxication with a Common Antituberculosis Drug
por: Lahlou, Adnane, et al.
Publicado: (2019)

Aureolic Acid Group of Agents as Potential Antituberculosis Drugs
por: Bespyatykh, Julia, et al.
Publicado: (2020)

Epidemiology of tuberculosis and susceptibility to antituberculosis drugs in Reunion Island
por: Loukman, Moreea, et al.
Publicado: (2023)

Drug-Induced Hepatotoxicity: Metabolic, Genetic and Immunological Basis
por: Njoku, Dolores B.
Publicado: (2014)

Clinical impact of plasma concentrations of first-line antituberculosis drugs
por: Perumal, R, et al.
Publicado: (2023)

Traditional Medicinal Plants as a Source of Antituberculosis Drugs: A System Review
por: Xu, Yuhui, et al.
Publicado: (2021)

Adverse drug reaction profile of daily regimen antituberculosis treatment
por: Sankar, K. N. Hari, et al.
Publicado: (2022)

Associations of GCLM, gclc and GSTP1 gene polymorphisms and antituberculosis drugs-induced hepatitis
por: Kim, Sang-Heon, et al.
Publicado: (2015)

Antituberculosis Drug-Induced Liver Injury with Autoimmune Features: Facing Diagnostic and Treatment Challenges
por: Rangel, Maria Adriana, et al.
Publicado: (2017)

The Variant at TGFBRAP1 but Not TGFBR2 Is Associated with Antituberculosis Drug-Induced Liver Injury
por: Zhang, Jingwei, et al.
Publicado: (2019)

Antituberculosis Drugs (Rifampicin and Isoniazid) Induce Liver Injury by Regulating NLRP3 Inflammasomes
por: Su, Qiang, et al.
Publicado: (2021)

Genetic Polymorphisms of UDP-Glucuronosyltransferases and Susceptibility to Antituberculosis Drug-Induced Liver Injury: A Systematic Review and Meta-Analysis
por: Chen, Xinyu, et al.
Publicado: (2023)

Population Pharmacokinetics of the Antituberculosis Agent Pretomanid
por: Salinger, David H., et al.
Publicado: (2019)

Suboptimal Antituberculosis Drug Concentrations and Outcomes in Small and HIV‐Coinfected Children in India: Recommendations for Dose Modifications
por: Guiastrennec, Benjamin, et al.
Publicado: (2018)

Empirical use of antituberculosis drugs should not be equated to their inappropriate and indiscriminate use
por: Kumar, Ramesh
Publicado: (2011)

Biosynthetic and Synthetic Strategies for Assembling Capuramycin-Type Antituberculosis Antibiotics
por: Biecker, Ashley L., et al.
Publicado: (2019)

Five-antituberculosis Drug-resistance Genes Detection Using Array System
por: Shimizu, Yasuo, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_hf5m7o55oftdqe7h5tif68h014